{
  "vaccine_designs": {
    "mRNA": {
      "platform": "mRNA",
      "selected_epitopes": [
        {
          "id": "epitope_1",
          "sequence": "YLQPRTFLL",
          "epitope_type": "T-cell",
          "prediction_score": 0.85
        },
        {
          "id": "epitope_2",
          "sequence": "KIADYNYKL",
          "epitope_type": "T-cell",
          "prediction_score": 0.78
        },
        {
          "id": "epitope_3",
          "sequence": "SLYNTVATL",
          "epitope_type": "T-cell",
          "prediction_score": 0.72
        },
        {
          "id": "epitope_4",
          "sequence": "GILGFVFTL",
          "epitope_type": "T-cell",
          "prediction_score": 0.68
        },
        {
          "id": "epitope_5",
          "sequence": "FIAGLIAIV",
          "epitope_type": "T-cell",
          "prediction_score": 0.65
        }
      ],
      "mrna_sequence": {
        "length": 243,
        "gc_content": 65.4320987654321,
        "codon_optimization_score": 0.85,
        "sequence": "ATGAAGTGGGTGACCTTCATCAGCCTGCTGTTCCTGTTTCTGAGCGCCGCCAGAAGCTACCTGCAGCCCCGCACCTTCCTGCTGGGCGGCAGCGGCAAGA..."
      },
      "stability_metrics": {
        "overall_stability_score": 0.678079012345679,
        "gc_content": 65.4320987654321,
        "predicted_half_life_hours": 28.273896296296297,
        "degradation_resistance": "low",
        "storage_stability": "good"
      },
      "formulation": {
        "composition": {
          "ionizable_lipid": "ALC-0315",
          "helper_lipid": "DSPC",
          "cholesterol": "cholesterol",
          "peg_lipid": "ALC-0159",
          "molar_ratios": [
            50,
            10,
            38.5,
            1.5
          ],
          "n_p_ratio": 6.0
        },
        "parameters": {
          "particle_size_nm": 80,
          "pdi": 0.1,
          "zeta_potential_mv": -5,
          "encapsulation_efficiency": 0.85,
          "mrna_concentration_mg_ml": 1.0,
          "buffer": "PBS_pH_7.4",
          "osmolality_mosm_kg": 300
        },
        "stability_profile": {
          "storage_temp_c": -70,
          "shelf_life_months": 6,
          "freeze_thaw_cycles": 1
        },
        "manufacturing_complexity": "medium",
        "cost_impact": "moderate"
      },
      "manufacturing": {
        "synthesis_method": "in_vitro_transcription",
        "template_dna_required": true,
        "purification_steps": [
          "DNase_treatment",
          "column_chromatography",
          "ultrafiltration"
        ],
        "yield_percentage": 65,
        "purity_percentage": 95,
        "endotoxin_level_eu_ml": 0.1,
        "production_time_days": 7,
        "batch_size_doses": 10000,
        "cost_per_dose_usd": 15.0,
        "scalability": "high",
        "quality_control_tests": [
          "identity_sequencing",
          "purity_hplc",
          "integrity_gel_electrophoresis",
          "endotoxin_lal",
          "sterility"
        ]
      },
      "predicted_efficacy": {
        "predicted_efficacy": 1.0,
        "confidence_interval": [
          0.9,
          1.1
        ],
        "factors": {
          "epitope_quality": 0.736,
          "stability_contribution": 0.13561580246913582,
          "platform_bonus": 0.15
        },
        "expected_immune_response": {
          "antibody_response": "strong",
          "cd8_response": "strong",
          "cd4_response": "moderate",
          "memory_formation": "good"
        }
      },
      "safety_profile": {
        "overall_safety_score": 0.85,
        "known_risks": [
          "injection_site_reactions",
          "mild_systemic_reactions",
          "rare_allergic_reactions"
        ],
        "contraindications": [
          "severe_immunocompromise",
          "known_peg_allergy"
        ],
        "special_populations": {
          "pregnancy": "use_with_caution",
          "pediatric": "age_dependent",
          "elderly": "generally_safe",
          "immunocompromised": "reduced_efficacy_expected"
        },
        "long_term_safety": "good_profile_expected",
        "regulatory_precedent": "established_covid_vaccines"
      },
      "regulatory_considerations": {
        "regulatory_pathway": "biologics_license_application",
        "precedent": "covid_mrna_vaccines",
        "key_requirements": [
          "sequence_characterization",
          "manufacturing_controls",
          "nonclinical_studies",
          "clinical_trials_phase_1_3"
        ],
        "timeline_estimate_months": 36,
        "major_regulatory_bodies": [
          "FDA",
          "EMA",
          "PMDA",
          "Health_Canada"
        ],
        "special_considerations": [
          "novel_antigen_characterization",
          "immunogenicity_assessment",
          "duration_of_immunity"
        ]
      }
    },
    "viral_vector": {
      "platform": "viral_vector",
      "selected_epitopes": [
        {
          "id": "epitope_1",
          "sequence": "YLQPRTFLL",
          "epitope_type": "T-cell",
          "prediction_score": 0.85
        },
        {
          "id": "epitope_2",
          "sequence": "KIADYNYKL",
          "epitope_type": "T-cell",
          "prediction_score": 0.78
        },
        {
          "id": "epitope_3",
          "sequence": "SLYNTVATL",
          "epitope_type": "T-cell",
          "prediction_score": 0.72
        },
        {
          "id": "epitope_4",
          "sequence": "GILGFVFTL",
          "epitope_type": "T-cell",
          "prediction_score": 0.68
        },
        {
          "id": "epitope_5",
          "sequence": "FIAGLIAIV",
          "epitope_type": "T-cell",
          "prediction_score": 0.65
        }
      ],
      "vector_system": {
        "vector_type": "adenovirus_5",
        "properties": {
          "immunogenicity": 0.9,
          "safety": 0.8,
          "manufacturing": 0.7,
          "regulatory": 0.9,
          "pre_existing_immunity": 0.3
        },
        "capacity_bp": 8000,
        "tropism": "broad",
        "replication": "replication_deficient"
      },
      "insert_design": {
        "promoter": "CMV_immediate_early",
        "signal_peptide": "tissue_plasminogen_activator",
        "epitope_cassette": "YLQPRTFLLGGSGKIADYNYKLGGSGSLYNTVATLGGSGGILGFVFTLGGSGFIAGLIAIV",
        "kozak_sequence": "GCCACC",
        "polya_signal": "SV40_polya",
        "total_length_bp": 783
      },
      "vector_assessment": {
        "pre_existing_immunity": {
          "prevalence": 0.3,
          "impact_on_efficacy": "moderate",
          "mitigation_strategies": [
            "prime_boost",
            "alternative_vectors"
          ]
        },
        "insert_stability": {
          "genetic_stability": "good",
          "expression_level": "high",
          "duration": "transient"
        },
        "biodistribution": {
          "target_tissues": [
            "muscle",
            "draining_lymph_nodes"
          ],
          "systemic_exposure": "limited",
          "clearance_mechanism": "immune_mediated"
        }
      },
      "manufacturing": {
        "production_system": "HEK293_cells",
        "purification_method": "cesium_chloride_gradient",
        "yield_particles_per_ml": 1000000000000.0,
        "purity_percentage": 90,
        "production_time_weeks": 4,
        "batch_size_doses": 50000,
        "cost_per_dose_usd": 45.0,
        "scalability": "medium",
        "quality_control": [
          "vector_genome_titer",
          "infectious_titer",
          "purity_sds_page",
          "sterility",
          "endotoxin"
        ]
      },
      "predicted_efficacy": {
        "predicted_efficacy": 0.8460000000000001,
        "confidence_interval": [
          0.6960000000000001,
          0.9460000000000001
        ],
        "expected_immune_response": {
          "antibody_response": "strong",
          "cd8_response": "very_strong",
          "cd4_response": "strong",
          "memory_formation": "excellent"
        }
      },
      "safety_profile": {
        "overall_safety_score": 0.8,
        "known_risks": [
          "injection_site_reactions",
          "flu_like_symptoms",
          "rare_thrombotic_events"
        ],
        "contraindications": [
          "severe_immunodeficiency",
          "pregnancy_caution"
        ],
        "monitoring_requirements": [
          "platelet_count",
          "coagulation_parameters"
        ]
      },
      "regulatory_considerations": {
        "regulatory_pathway": "biologics_license_application",
        "precedent": "covid_vector_vaccines",
        "timeline_estimate_months": 42,
        "special_requirements": [
          "vector_characterization",
          "biodistribution_studies",
          "shedding_studies"
        ]
      }
    },
    "peptide": {
      "platform": "peptide",
      "selected_peptides": [
        {
          "id": "epitope_1",
          "sequence": "YLQPRTFLL",
          "epitope_type": "T-cell",
          "prediction_score": 0.85,
          "properties": {
            "length": 9,
            "molecular_weight_da": 990,
            "hydrophobicity": 0.28888888888888886,
            "net_charge": 1,
            "polar_residue_fraction": 0.4444444444444444,
            "solubility_prediction": "moderate",
            "stability_prediction": "stable",
            "aggregation_propensity": "low"
          },
          "optimizations": {
            "optimized_sequence": "YLQPRTFLL",
            "modifications": [],
            "rationale": []
          },
          "final_sequence": "YLQPRTFLL"
        },
        {
          "id": "epitope_2",
          "sequence": "KIADYNYKL",
          "epitope_type": "T-cell",
          "prediction_score": 0.78,
          "properties": {
            "length": 9,
            "molecular_weight_da": 990,
            "hydrophobicity": -0.8111111111111111,
            "net_charge": 1,
            "polar_residue_fraction": 0.6666666666666666,
            "solubility_prediction": "good",
            "stability_prediction": "stable",
            "aggregation_propensity": "low"
          },
          "optimizations": {
            "optimized_sequence": "KIADYNYKL",
            "modifications": [],
            "rationale": []
          },
          "final_sequence": "KIADYNYKL"
        },
        {
          "id": "epitope_3",
          "sequence": "SLYNTVATL",
          "epitope_type": "T-cell",
          "prediction_score": 0.72,
          "properties": {
            "length": 9,
            "molecular_weight_da": 990,
            "hydrophobicity": 0.7333333333333333,
            "net_charge": 0,
            "polar_residue_fraction": 0.5555555555555556,
            "solubility_prediction": "moderate",
            "stability_prediction": "stable",
            "aggregation_propensity": "low"
          },
          "optimizations": {
            "optimized_sequence": "SLYNTVATL",
            "modifications": [],
            "rationale": []
          },
          "final_sequence": "SLYNTVATL"
        },
        {
          "id": "epitope_4",
          "sequence": "GILGFVFTL",
          "epitope_type": "T-cell",
          "prediction_score": 0.68,
          "properties": {
            "length": 9,
            "molecular_weight_da": 990,
            "hydrophobicity": 2.266666666666667,
            "net_charge": 0,
            "polar_residue_fraction": 0.1111111111111111,
            "solubility_prediction": "poor",
            "stability_prediction": "stable",
            "aggregation_propensity": "moderate"
          },
          "optimizations": {
            "optimized_sequence": "GILGFVFTL",
            "modifications": [
              "add_solubilizing_tag"
            ],
            "rationale": [
              "Improve solubility with hydrophilic tag"
            ]
          },
          "final_sequence": "GILGFVFTL"
        },
        {
          "id": "epitope_5",
          "sequence": "FIAGLIAIV",
          "epitope_type": "T-cell",
          "prediction_score": 0.65,
          "properties": {
            "length": 9,
            "molecular_weight_da": 990,
            "hydrophobicity": 3.0555555555555554,
            "net_charge": 0,
            "polar_residue_fraction": 0.0,
            "solubility_prediction": "poor",
            "stability_prediction": "stable",
            "aggregation_propensity": "high"
          },
          "optimizations": {
            "optimized_sequence": "FIAGLIAIV",
            "modifications": [
              "add_solubilizing_tag",
              "spacer_residues"
            ],
            "rationale": [
              "Improve solubility with hydrophilic tag",
              "Add spacer residues to prevent aggregation"
            ]
          },
          "final_sequence": "FIAGLIAIV"
        }
      ],
      "adjuvant_system": {
        "adjuvant_name": "MF59",
        "selection_score": 0.9500000000000001,
        "properties": {
          "type": "oil_in_water_emulsion",
          "mechanism": "immune_activation",
          "immune_response": "Th1/Th2_balanced",
          "compatibility": [
            "peptide",
            "protein_subunit"
          ],
          "safety_profile": "good",
          "cost": "medium"
        },
        "dosage_recommendation": {
          "amount_ml": 0.5,
          "volume_ml": 0.5
        },
        "administration_route": "intramuscular"
      },
      "formulation": {
        "peptide_concentration_mg_ml": 1.0,
        "total_peptide_dose_mg": 0.1,
        "adjuvant_system": {
          "adjuvant_name": "MF59",
          "selection_score": 0.9500000000000001,
          "properties": {
            "type": "oil_in_water_emulsion",
            "mechanism": "immune_activation",
            "immune_response": "Th1/Th2_balanced",
            "compatibility": [
              "peptide",
              "protein_subunit"
            ],
            "safety_profile": "good",
            "cost": "medium"
          },
          "dosage_recommendation": {
            "amount_ml": 0.5,
            "volume_ml": 0.5
          },
          "administration_route": "intramuscular"
        },
        "buffer_system": "phosphate_buffered_saline",
        "ph": 7.4,
        "osmolality_mosm_kg": 300,
        "preservative": "none",
        "stabilizers": [
          "sucrose",
          "polysorbate_80"
        ],
        "storage_conditions": {
          "temperature_c": 4,
          "light_protection": true,
          "shelf_life_months": 24
        },
        "administration": {
          "route": "intramuscular",
          "volume_ml": 0.5,
          "injection_site": "deltoid_muscle"
        }
      },
      "manufacturing": {
        "synthesis_method": "solid_phase_peptide_synthesis",
        "purification_method": "reverse_phase_hplc",
        "yield_percentage": 75,
        "purity_percentage": 98,
        "production_time_weeks": 2,
        "batch_size_doses": 100000,
        "cost_per_dose_usd": 25.0,
        "scalability": "high",
        "quality_control": [
          "mass_spectrometry",
          "amino_acid_analysis",
          "hplc_purity",
          "endotoxin_testing",
          "sterility"
        ]
      },
      "predicted_efficacy": {
        "predicted_efficacy": 0.9785,
        "confidence_interval": [
          0.8585,
          1.0585
        ],
        "expected_immune_response": {
          "antibody_response": "moderate",
          "cd8_response": "strong",
          "cd4_response": "strong",
          "memory_formation": "good"
        }
      },
      "safety_profile": {
        "overall_safety_score": 0.9,
        "known_risks": [
          "injection_site_reactions",
          "adjuvant_related_reactions"
        ],
        "contraindications": [
          "known_peptide_allergies",
          "adjuvant_specific_contraindications"
        ],
        "special_populations": {
          "pregnancy": "generally_safe",
          "pediatric": "safe_with_dose_adjustment",
          "elderly": "safe",
          "immunocompromised": "safe_but_reduced_efficacy"
        }
      },
      "regulatory_considerations": {
        "regulatory_pathway": "biologics_license_application",
        "precedent": "established_peptide_vaccines",
        "timeline_estimate_months": 30,
        "key_requirements": [
          "peptide_characterization",
          "adjuvant_qualification",
          "nonclinical_studies",
          "clinical_trials"
        ]
      }
    },
    "protein_subunit": {
      "platform": "protein_subunit",
      "protein_design": {
        "signal_peptide": "native_or_optimized",
        "epitope_regions": [
          {
            "id": "epitope_1",
            "sequence": "YLQPRTFLL",
            "epitope_type": "T-cell",
            "prediction_score": 0.85
          },
          {
            "id": "epitope_2",
            "sequence": "KIADYNYKL",
            "epitope_type": "T-cell",
            "prediction_score": 0.78
          },
          {
            "id": "epitope_3",
            "sequence": "SLYNTVATL",
            "epitope_type": "T-cell",
            "prediction_score": 0.72
          },
          {
            "id": "epitope_4",
            "sequence": "GILGFVFTL",
            "epitope_type": "T-cell",
            "prediction_score": 0.68
          },
          {
            "id": "epitope_5",
            "sequence": "FIAGLIAIV",
            "epitope_type": "T-cell",
            "prediction_score": 0.65
          }
        ],
        "linker_sequences": [
          "GGSG",
          "EAAAK"
        ],
        "purification_tag": "his6_tag",
        "total_length_aa": 61,
        "molecular_weight_kda": 6.71,
        "predicted_structure": "mixed_alpha_beta",
        "solubility_prediction": "good"
      },
      "expression_system": {
        "system": "E.coli",
        "properties": {
          "cost": "low",
          "speed": "fast",
          "yield": "high",
          "post_translational_modifications": false,
          "endotoxin_risk": true,
          "scalability": "excellent"
        },
        "strain_recommendation": "BL21_DE3"
      },
      "purification_strategy": {
        "purification_steps": [
          {
            "step": "immobilized_metal_affinity_chromatography",
            "resin": "ni_nta",
            "expected_purity": 85,
            "yield": 80
          },
          {
            "step": "size_exclusion_chromatography",
            "purpose": "aggregate_removal",
            "expected_purity": 95,
            "yield": 90
          },
          {
            "step": "endotoxin_removal",
            "method": "polymyxin_b_chromatography",
            "target_level": "<1_EU_mg",
            "yield": 95
          }
        ],
        "overall_yield": 68,
        "final_purity": 95,
        "endotoxin_level": "<1_EU_mg",
        "process_time_days": 3
      },
      "adjuvant_system": {
        "adjuvant_name": "MF59",
        "selection_score": 0.9500000000000001,
        "properties": {
          "type": "oil_in_water_emulsion",
          "mechanism": "immune_activation",
          "immune_response": "Th1/Th2_balanced",
          "compatibility": [
            "peptide",
            "protein_subunit"
          ],
          "safety_profile": "good",
          "cost": "medium"
        },
        "dosage_recommendation": {
          "amount_ml": 0.5,
          "volume_ml": 0.5
        },
        "administration_route": "intramuscular"
      },
      "manufacturing": {
        "fermentation_time_hours": 48,
        "harvest_yield_g_l": 2.0,
        "purification_yield_percentage": 68,
        "final_concentration_mg_ml": 10,
        "batch_size_doses": 75000,
        "production_time_weeks": 3,
        "cost_per_dose_usd": 20.0,
        "scalability": "high",
        "quality_control": [
          "sds_page_purity",
          "mass_spectrometry",
          "endotoxin_lal",
          "bioactivity_assay",
          "sterility"
        ]
      },
      "predicted_efficacy": {
        "predicted_efficacy": 0.80342,
        "confidence_interval": [
          0.70342,
          0.90342
        ],
        "expected_immune_response": {
          "antibody_response": "strong",
          "cd8_response": "moderate",
          "cd4_response": "strong",
          "memory_formation": "excellent"
        }
      },
      "safety_profile": {
        "overall_safety_score": 0.88,
        "known_risks": [
          "injection_site_reactions",
          "adjuvant_related_reactions",
          "rare_allergic_reactions"
        ],
        "contraindications": [
          "known_protein_allergies",
          "adjuvant_contraindications"
        ],
        "special_populations": {
          "pregnancy": "generally_safe",
          "pediatric": "safe",
          "elderly": "safe",
          "immunocompromised": "safe_but_reduced_response"
        }
      },
      "regulatory_considerations": {
        "regulatory_pathway": "biologics_license_application",
        "precedent": "established_protein_vaccines",
        "timeline_estimate_months": 33,
        "key_requirements": [
          "protein_characterization",
          "manufacturing_validation",
          "nonclinical_studies",
          "clinical_trials"
        ]
      }
    }
  },
  "platform_comparison": {
    "platform_metrics": {
      "mRNA": {
        "predicted_efficacy": 1.0,
        "safety_score": 0.85,
        "manufacturing_complexity": 0.6,
        "cost_per_dose": 15.0,
        "development_timeline": 36,
        "scalability_score": 0.8,
        "overall_score": 0.7925
      },
      "viral_vector": {
        "predicted_efficacy": 0.8460000000000001,
        "safety_score": 0.8,
        "manufacturing_complexity": 0.6,
        "cost_per_dose": 45.0,
        "development_timeline": 42,
        "scalability_score": 0.6,
        "overall_score": 0.6438000000000001
      },
      "peptide": {
        "predicted_efficacy": 0.9785,
        "safety_score": 0.9,
        "manufacturing_complexity": 0.6,
        "cost_per_dose": 25.0,
        "development_timeline": 30,
        "scalability_score": 0.8,
        "overall_score": 0.7885500000000001
      },
      "protein_subunit": {
        "predicted_efficacy": 0.80342,
        "safety_score": 0.88,
        "manufacturing_complexity": 0.6,
        "cost_per_dose": 20.0,
        "development_timeline": 33,
        "scalability_score": 0.8,
        "overall_score": 0.7360260000000001
      }
    },
    "ranked_platforms": [
      "mRNA",
      "peptide",
      "protein_subunit",
      "viral_vector"
    ],
    "top_recommendation": "mRNA",
    "comparison_summary": {
      "best_efficacy": {
        "platform": "mRNA",
        "score": 1.0
      },
      "best_safety": {
        "platform": "peptide",
        "score": 0.9
      },
      "lowest_cost": {
        "platform": "mRNA",
        "cost": 15.0
      },
      "fastest_development": {
        "platform": "peptide",
        "months": 30
      },
      "average_efficacy": 0.90698,
      "average_safety": 0.8574999999999999,
      "cost_range": [
        15.0,
        45.0
      ]
    }
  },
  "recommendations": [
    {
      "type": "primary_recommendation",
      "platform": "mRNA",
      "priority": "high",
      "rationale": "mRNA shows the best overall profile for cancer",
      "next_steps": [
        "Conduct detailed feasibility study",
        "Initiate preclinical development",
        "Engage with regulatory authorities"
      ]
    },
    {
      "type": "alternative_recommendation",
      "platform": "peptide",
      "priority": "medium",
      "rationale": "peptide as backup or parallel development option",
      "considerations": [
        "Risk mitigation strategy",
        "Different regulatory pathway",
        "Complementary immune response profile"
      ]
    },
    {
      "type": "context_specific",
      "recommendation": "Consider combination approaches",
      "rationale": "Cancer vaccines often benefit from multi-modal approaches",
      "suggestions": [
        "Prime-boost strategies",
        "Combination with checkpoint inhibitors",
        "Personalized neoantigen approaches"
      ]
    },
    {
      "type": "manufacturing",
      "recommendation": "Establish manufacturing partnerships early",
      "rationale": "Manufacturing capabilities are critical for success",
      "actions": [
        "Identify qualified manufacturers",
        "Negotiate technology transfer agreements",
        "Plan for scale-up requirements"
      ]
    }
  ],
  "manufacturing_assessment": {
    "overall_feasibility": "good",
    "platform_assessments": {
      "mRNA": {
        "complexity_score": 0.6,
        "scalability_score": 0.8,
        "cost_competitiveness": "competitive",
        "timeline_feasibility": "moderate",
        "risk_factors": [
          "Cold chain requirements",
          "Lipid nanoparticle stability",
          "RNA degradation",
          "Specialized equipment needs"
        ]
      },
      "viral_vector": {
        "complexity_score": 0.6,
        "scalability_score": 0.6,
        "cost_competitiveness": "moderate",
        "timeline_feasibility": "moderate",
        "risk_factors": [
          "Cell culture contamination",
          "Vector stability",
          "Purification complexity",
          "Batch-to-batch variability"
        ]
      },
      "peptide": {
        "complexity_score": 0.6,
        "scalability_score": 0.8,
        "cost_competitiveness": "competitive",
        "timeline_feasibility": "fast",
        "risk_factors": [
          "Peptide aggregation",
          "Chemical stability",
          "Adjuvant compatibility",
          "Synthesis scale-up"
        ]
      },
      "protein_subunit": {
        "complexity_score": 0.6,
        "scalability_score": 0.8,
        "cost_competitiveness": "competitive",
        "timeline_feasibility": "fast",
        "risk_factors": [
          "Protein folding",
          "Endotoxin contamination",
          "Expression system limitations",
          "Purification yield"
        ]
      }
    },
    "critical_factors": [
      "Supply chain reliability",
      "Quality control capabilities",
      "Regulatory compliance",
      "Scale-up challenges",
      "Cost optimization"
    ],
    "recommendations": [
      "Conduct detailed manufacturing feasibility studies",
      "Establish quality by design principles",
      "Plan for regulatory inspections",
      "Develop robust supply chain strategies",
      "Implement continuous improvement processes"
    ]
  }
}